Morbid Obesity: Gastric Bypass and Sleeve Gastrectomy Are Comparable
Morbid obesity and associated diseases such as diabetes, cardiovascular diseases and cancer are widespread in the western world. Surgical interventions are currently considered to be the most effective measure in severely obese people with a BMI over 35.
The standard surgery is a gastric bypass, where part of the stomach and small intestine is bypassed. Other methods are also becoming more popular, such as sleeve gastrectomy, in which the volume of the stomach is reduced. This operation is technically easier to perform and can be done with low complication rate even in patients with very high BMI.
More than 200 patients examined
To compare these two common types of surgery, the study looked at 217 morbidly obese patients; half were assigned to a gastric bypass and half a sleeve gastrectomy. Their average age was 45.5 years, and 72% of them were women. The study was conducted at four locations in Switzerland and was led by Professor Ralph Peterli from the University of Basel at St. Claraspital.
In terms of weight loss, the two types of surgery led to similar results five years after the surgery: the patients lost 68% of their excess weight after a gastric bypass, and 61% after a sleeve gastrectomy. The BMI also fell from 44 to 32 after both operations. Associated diseases such as hypertension, diabetes, altered blood lipids, back/joint pain and depression were also improved, as well as general quality of life.
Improvement in gastric acid reflux
Patients with existing gastric acid reflux benefited more from a gastric bypass operation: after this procedure, symptoms were eliminated in 60%, compared to only 25% after a sleeve gastrectomy. Sleeve gastrectomy also led to a deterioration or new onset of gastric acid reflux significantly more often. Further surgery or interventions were needed in 22% of gastric bypasses and 16% of sleeve gastrectomy operations.
Original source
Ralph Peterli et al.
Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial
JAMA (2018), doi: 10.1001/jama.2017.20897
Further information
Prof. Dr. Ralph Peterli, University of Basel and St. Claraspital Basel, phone: +41 61 685 84 84, email: ralph.peterli@claraspital.ch
https://www.unibas.ch/en/News-Events/News/Uni-Research/Morbid-Obesity.html
Media Contact
More Information:
http://www.unibas.chAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
A ‘language’ for ML models to predict nanopore properties
A large number of 2D materials like graphene can have nanopores – small holes formed by missing atoms through which foreign substances can pass. The properties of these nanopores dictate many…
Clinically validated, wearable ultrasound patch
… for continuous blood pressure monitoring. A team of researchers at the University of California San Diego has developed a new and improved wearable ultrasound patch for continuous and noninvasive…
A new puzzle piece for string theory research
Dr. Ksenia Fedosova from the Cluster of Excellence Mathematics Münster, along with an international research team, has proven a conjecture in string theory that physicists had proposed regarding certain equations….